Revenue
2022
2023
2024
2025
Nasus Pharma Ltd (NSRX)
Price—Loading quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $1.24B | $0 | $0 | $0 |
| Research & development | $2.2M | $335,000 | $567,000 | $1.1M |
| Operating expenses | $4.9M | $1.1M | $1.1M | $2.0M |
| Operating income | −$4.9M | −$1.1M | −$1.1M | −$2.0M |
| Operating margin | −0.40% | — | — | — |
| EBITDA | −$4.9M | −$1.1M | −$1.1M | −$2.1M |
| EBITDA margin | −0.40% | — | — | — |
| Net income | −$5.9M | −$1.5M | −$1.1M | −$1.7M |
| Net profit margin | −0.47% | — | — | — |
| Basic EPSper basic share | -$0.72 | -$0.22 | -$0.15 | -$0.24 |
| Diluted EPSper diluted share | -$0.72 | -$0.22 | -$0.20 | -$0.24 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Gilboa Udi | 1.92M |
Megiddo Dalia | 1.89M |
Hershman Ronnie | 1.34M |
Balyasny Asset Management L.P. | 898.47K |
Cable Car Capital, LP | 616.08K |
Velan Capital Investment Management LP | 359.39K |
Teleman Dan Benjamin | 163.54K |
Hudson Bay Capital Management LP | 134.77K |
Bleichroeder LP | 89.85K |
CITADEL ADVISORS LLC | 22K |
XTX Topco Ltd | 16.64K |
RENAISSANCE TECHNOLOGIES LLC | 12.2K |
MORGAN STANLEY | 1K |
Caitong International Asset Management Co., Ltd | 4 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 17, 2026Form 4 | Teleman Dan BenjaminChief Executive Officer | BuyOrdinary Shares | 6.5K | $3.10 | $20.3K | 163.5K |
| Apr 22, 2026Form 4 | Teleman Dan BenjaminChief Executive Officer | BuyOrdinary Shares | 2.9K | $3.76 | $10.9K | 157.0K |
| Mar 31, 2026Form 4 | Teleman Dan BenjaminChief Executive Officer | BuyOrdinary Shares | 15.0K | $2.04 | $30.6K | 21.2K |